HMG-COA REDUCTASE INHIBITORS (STATINS) ASSOCIATED TENDON RUPTURE: AN ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE REPORTING SYSTEM

被引：0
|
作者：
Rafi, J. A. [1 ]
Arabyat, R. [1 ]
Chen, C. [1 ]
Raisch, D. W. [1 ]
机构：
[1] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.066
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV1
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [41] Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
    Battini, Vera
    Carnovale, Carla
    Clementi, Emilio
    Sessa, Maurizio
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (11) : 1105 - 1112
  • [42] Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
    Liang, Yankun
    Ma, Lin
    Wang, Yuting
    Zheng, Jingping
    Su, Ling
    Lyu, Jun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [43] Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data
    Bayram, Ferit
    Akici, Ahmet
    Apari, Asli Melda
    Aydin, Volkan
    INTERNATIONAL DENTAL JOURNAL, 2025, 75 (03) : 1705 - 1712
  • [44] Drug-Induced Hair Loss: Analysis of the Food and Drug Administration's Adverse Events Reporting System Database
    Hill, Rachel C.
    Zeldin, Steven D.
    Lipner, Shari R.
    SKIN APPENDAGE DISORDERS, 2025, 11 (01) : 63 - 69
  • [45] Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature
    Raisch, Dennis W.
    Garg, Vishvas
    Arabyat, Rasha
    Shen, Xian
    Edwards, Beatrice J.
    Miller, Frank H.
    McKoy, June M.
    Nardone, Beatrice
    West, Dennis P.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (01) : 15 - 23
  • [46] RHEUMATIC AND MUSCULOSKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA MINING OF THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM
    Pundole, X.
    Sarangdhar, M.
    Suarez-Almazor, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 147 - 148
  • [47] Malignant melanoma cases associated with IL-23 inhibitors: Pharmacovigilance analysis of real-world evidence in the Food and Drug Administration Adverse Event Reporting System (FAERS) from the RADAR (Research on Adverse Drug events And Reports) program
    Kahen, Negar
    Ali, Yasmeen
    West, Dennis P.
    Nardone, Beatrice
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB182 - AB182
  • [48] Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System
    Pundole, Xerxes
    Shah, Mohsin
    Abdel-Wahab, Noha
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [49] Olfactory-Related Adverse Events: An Analysis of the Food and Drug Administration Adverse Events Reporting System
    Minutello, Katrina M.
    Lofgren, Daniel H.
    Lenkeit, Christopher P.
    Emmer, Eriel
    Rivera, Olga Santiago
    Hasan, Md Sakibur
    Downs, Asha
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (05) : 1296 - 1306
  • [50] Intestinal Adverse Outcomes With Pancreatic Enzymes: An Analysis of the Food and Drug Administration Adverse Event Reporting System
    Stobaugh, Derrick J.
    Deepak, Parakkal
    Ehrenpreis, Eli D.
    GASTROENTEROLOGY, 2013, 144 (05) : S457 - S457
12345